Mercator MedicalFRA:MM2 +0.18%60 ROA % is 5.09% as of Mar. 2026, which is 100% above its 10-year median of 2.54. GuruFocus rates FRA:MM2 with a GF Score™ of 60/100 and a GF Value™ of €11.48 (Fairly Valued). The stock has 2 warning signs investors should review. Among 857 Medical Devices & Instruments companies, Mercator Medical ranks better than 52.39% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Mercator Medical's annualizedNet Income for the quarter that ended in Mar. 2026 was €12.3 Mil.
Mercator Medical's average Total Assets over the quarter that ended in Mar. 2026 was €241.3 Mil. Therefore, Mercator Medical's annualized ROA % for the quarter that ended in Mar. 2026 was 5.09%.
The historical rank and industry rank for Mercator Medical's ROA % or its related term are showing as below:
FRA:MM2'
s ROA % Range Over the Past 10 Years
Min: -15.99 Med: 2.54 Max: 111
Current: 1.17
During the past 13 years, Mercator Medical's highest ROA % was 111.00%. The lowest was -15.99%. And the median was 2.54%.
FRA:MM2's ROA % is ranked better than 52.39% of 857
companies
in the Medical Devices & Instruments industry
Industry Median: 0.56
vs FRA:MM2: 1.17
Mercator Medical (FRA:MM2) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Mercator Medical ROA % Related Terms
Mercator Medical ROA % Historical Data
* Premium members only.
The historical data trend for Mercator Medical's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Mercator Medical's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mercator Medical ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mercator Medical's ROA % distribution charts can be found below:
* The bar in red indicates where Mercator Medical's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Mercator Medical (FRA:MM2) has a ROA % of 5.09% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Mercator Medical and its competitors. This is 100% above median its historical median of 2.54. According to the industry distribution chart, Mercator Medical ranks #408 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 47.6%.
Is Mercator Medical's ROA % too high?
Mercator Medical's current ROA % of 5.09% is 100% above median its 10-year median of 2.54. The Medical Devices & Instruments industry median ROA % is 0.56. Mercator Medical's value of 5.09% is 808.9% above this industry median. Based on the distribution chart, Mercator Medical ranks #408 out of 857 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Mercator Medical has a GF Score™ of 60/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Mercator Medical ranks #408 out of 857 companies for ROA %. This puts Mercator Medical in the upper half of its industry. The industry median ROA % is 0.56. Mercator Medical's value of 5.09% is 808.9% above this benchmark. While the company's 10-year median is 2.54 vs. the industry median of 0.56, Mercator Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.56, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mercator Medical's current ROA % of 5.09% is 808.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Mercator Medical and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mercator Medical's current ROA % is 5.09%, which is 100% above median its own 10-year median of 2.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Based on GuruFocus' analysis, Mercator Medical (FRA:MM2) is currently considered Fairly Valued. The stock's GF Value™ is €11.48, compared to a current price of €11.20 — trading 2.4% below its estimated fair value. The current ROA % is 5.09%, which is 100% above median its 10-year median of 2.54 and 808.9% above the Medical Devices & Instruments industry median of 0.56. Mercator Medical's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Mercator Medical (FRA:MM2), the current ROA % is 5.09% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mercator Medical (FRA:MM2) Overvalued in 2026?
Based on GuruFocus' analysis, Mercator Medical stock appears to be undervalued.
The current stock price of €11.20 is trading 2.4% below its estimated GF Value™ of €11.48.
GuruFocus considers Mercator Medical to be Fairly Valued.
Key valuation signals for FRA:MM2:
ROA %: 5.09% (100% above median its 10-year median of 2.54)
GF Value™: €11.48 vs. price of €11.20 (2.4% below fair value)
Industry Position: 808.9% above the Medical Devices & Instruments median (#408 of 857)
No single metric tells the full story. See the FRA:MM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
60GF Score
Get the complete analysis for FRA:MM2
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MM2 has been successfully added to your 
